Lumis International GmbH spins off its consulting business to Lumis Life Science Consulting GmbHPosted Oct 29, 2020
Berlin, 29.10.2020 – Lumis International GmbH (“Lumis”) announced today that its recently founded spin-off company, Lumis Life Science Consulting GmbH (“Lumis Consult”), has taken over Lumis’ consulting services for small to midsized biopharmaceutical companies.
The foundation of Lumis Consult allows Lumis to expand its consulting business in a major strategic step. It reflects the increasing demand by biopharmaceutical companies for support in accelerating the clinical development of innovative drugs and medical devices. Lumis Consult understands itself as a reliable and well positioned partner of these companies, offering them a comprehensive and qualified support to facilitate outsourcing of clinical trials, to manage vendors efficiently and to maintain full oversight of clinical projects at any time.
Lumis and Lumis Consult are run by the same experienced management team. Heike Schön, Managing Director and Co-Founder of the two companies, comments: “I am very glad that we augment our consulting services by establishing Lumis Consult. Our experts know both the vendor’s and the sponsor’s side from hands-on experience, so they identify issues in clinical projects easily and can effectively prevent and resolve them. We want to enable sponsors and vendors to work together in a successful and trustful business relationship.”
In June 2020, Dr. Christiane Juhls became the Project Director of Lumis Consult. She has more than 20 years of experience in research and development of vaccines and drugs, including over 16 years managing international projects for a biotechnology company. Dr. Juhls complements the team of highly specialised consultants and will play a key role in further developing the business of Lumis Consult.
About Lumis International GmbH
Lumis International GmbH is an experienced service organisation, has been founded in 2013 and is headquartered in Berlin, Germany. The company is specialised in providing legal representation and data representation services for biopharmaceutical and medical device companies who intend to develop their product for the European market but are located in non-EU countries around the globe.